stars 1 stars 2 stars 3

S.T.Stent develops a composite removable sinus stent. The stent is designed to be placed into ethmoid sinus following functional endoscopic sinus surgery (FESS) to maintain the cavity open. FESS procedure is used to treat chronic sinusitis, which is one of the most common health problems in the modern world. However a single surgery often is not enough to cure the patient, due to post surgery scarring, stenosis and middle turbinate lateralization. The stent is designed to keep the cavity open, long enough for the healing process to complete itself and can be removed at any time, based on patient decision or physician consult. Stent removal is an in-office procedure, done without anesthesia, and is minimally invasive for the patient.

S.T.Stent Questions

The S.T.Stent annual revenue was $1 million in 2026.

Joseph Flomenblit is the CEO and Founder of S.T.Stent.

1 people are employed at S.T.Stent.

The NAICS codes for S.T.Stent are [339, 33].

The SIC codes for S.T.Stent are [38, 384].

Top S.T.Stent Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users